Neurotech International Limited
NTI
Rank in Stocks
#26671
Neurotech International Limited (NTI.AX), along with its subsidiaries, is an... Neurotech International Limited (NTI.AX), along with its subsidiaries, is an Australian firm dedicated to the research, development, and manufacture of innovative medical devices and solutions. The company's primary focus lies in advancing and commercializing its Mente platform, a technological system designed to monitor and facilitate home-based therapies. This includes its Mente Autism product, specifically aimed at the diagnosis and treatment of autism spectrum disorder. Additionally, Neurotech actively undertakes various medical research projects and engineers new technological instruments. The company was established in 2016 and maintains its headquarters in Nedlands, Australia.
Share Price
$0.01176723
Last synced: 2026-11-10
Market Cap
$19.02M
Change (1 day)
6.25%
Change (1 year)
6.07%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Neurotech International Limited (NTI)
Category
Healthcare
Operating Margin for Neurotech International Limited (NTI)
Operating Margin as of November 2026 TTM: 0.00%
According to Neurotech International Limited's latest financial reports, its current operating margin (TTM) is 0.00%. At the end of 2025 the company had an operating margin of -453.62%.
Operating Margin history for Neurotech International Limited from 2016 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | 0.00% | -100.00% |
| 2025 | -453.62% | -99.90% |
| 2024 | -446,293.79% | 194.89% |
| 2023 | -151,342.34% | 1,377.18% |
| 2022 | -10,245.33% | 183.67% |
| 2021 | -3,611.72% | 120.03% |
| 2020 | -1,641.44% | 19.94% |
| 2019 | -1,368.59% | -89.03% |
| 2018 | -12,477.76% | 183.14% |
| 2017 | -4,406.90% | 212.41% |
| 2016 | -1,410.62% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 15.24% | - |
US
|
|
| 18.08% | - |
IE
|
|
| 21.25% | - |
US
|
|
| 21.05% | - |
US
|
|
| 28.09% | - |
US
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Neurotech International Limited's operating margin
What was Neurotech International Limited's operating margin in 2025?
In 2025, Neurotech International Limited's operating margin was -453.62%, compared with -446,293.79% in 2024.
How has Neurotech International Limited's operating margin changed since 2020?
From 2020 to 2025, Neurotech International Limited's operating margin was highest in 2025 (-453.62%) and lowest in 2024 (-446,293.79%).
How does Neurotech International Limited's operating margin compare with similar companies?
Neurotech International Limited's operating margin (0.00%) is lower than that of all 5 similar companies listed above. The highest among them is Edwards Lifesciences Corporation, with 28.09%.